CRP and bacterial infectious disease: In this Group, patients receiving placebo had an increase in CRP in the second week of the treatment period (Days 10–17) that, when combined with the increased incidence of purulent sputum, potentially suggests the presence of a secondary bacterial infection [26, 27].